Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,827 total articles
Norwegian Cruise Line (NCLH) offers a mid-term swing trade setup. Shares are discounted relative to peers, technical momentum is constructive and booking momentum from wave season should flow into revenue and pricing. We lay out an entry at $23.00, stop at $20.00 and a target of $28.00 over a 45 trading-day horizon, with clear triggers that would c…
WEX Inc. looks materially undervalued on cash flow and earnings multiples relative to its growth profile, but recent revenue softness, activist pressure and execution gaps in Mobility and Corporate Payments mean this is a trade, not a buy-and-forget. Enter a measured long at current levels with a firm stop and a target near the 52-week high - a mid…
Targa Resources (TRGP) is priced as a mature midstream owner but is funding a multi-billion dollar Permian buildout that should expand EBITDA and free cash flow over the next 12-18 months. With dividend increases, debt refinancing completed, and a clear pipeline of growth projects, the risk/reward favors loading a position now. This trade outlines …
Amazon has been hit hard in a broad tech selloff driven by AI capex fears. The drop has pushed technical indicators into deeply oversold territory while AWS growth and large-scale AI investment provide a clear fundamental runway. This trade idea lays out an actionable mid-term plan with entry, stop and target, and a balanced view of risks and catal…
Affirm has moved beyond promise to proof: GAAP profitability, accelerating gross merchandise volume, material free cash flow, and strategic partnerships create a clear path for margin expansion. The market's knee-jerk sell-off to $49.86 creates an actionable entry for a long position targeting a re-rating back toward growth multiple peers, with def…
FDA approval of Optune Pax for locally advanced pancreatic cancer materially broadens NovoCure's TAM and gives the stock a near-term re-rating lever. The catalyst is clear; the trade is to buy a measured entry on the post-announcement pullback with defined stop and target.
Arhaus has pulled back to $9.13 after a bout of selling that looks more technical than structural. The business is cash-generative, lightly levered, and expanding showrooms while raising revenue guidance in recent quarters. At roughly $1.29B market cap and a P/S near 1.0, this is a buy-the-dip setup with a clear entry, stop, and target for a mid-te…
Sanofi's board removed CEO Paul Hudson effective 02/17/2026 and named Belén Garijo as incoming CEO on 04/29/2026. The stock has pulled back to $47.03 after the news but trades at a market cap of $113.95B with a P/E of 13.63 and a 3.25% dividend yield. We view the sell-off as an overreaction and recommend a mid-term long with exact entry, stop and t…
Brinker posted crisp operating progress in FY2025: same-store gains at Chili's, restaurant operating margin expansion and >$5B in revenue. Valuation is reasonable (P/E ~16, EV/EBITDA ~10) for a mid-cap casual-dining operator. This is a swing trade idea to buy strength around $162.54, target $175 and protect capital at $156 if traffic momentum stall…
Fairfax Financial (FRFHF) has enjoyed a monster rally, yet core valuation metrics - PE ~7.9 and PB ~1.42 - still argue for more upside. Market cap sits near $40.0B while the company continues to generate substantial earnings and carry a diversified insurance + investment mix. This trade proposes a long with a clear entry, stop and target and balanc…
Microsoft's share price has pulled back with software peers amid macro concern, but the company's durable cloud growth, strong free cash flow ($77.4B), and pristine balance sheet make the current levels attractive. This is a tactical upgrade to BUY with a position-sized plan and clear entry, stop, and target levels for the next 3-6 months.
Boeing has posted improving profitability metrics but still shows negative free cash flow, heavy leverage and stretched multiples. The stock is a tactical long: buy the operational momentum and service-tail gains while protecting against execution and balance-sheet shocks. Entry $239.35, stop $218.00, target $280.00 for a long-term (180 trading day…
Salesforce (CRM) has been chopped down with the rest of SaaS as AI fear and headline risk dominate tape. Fundamentals still show a durable franchise: market cap ~$174B, free cash flow near $12.9B, low net leverage, and P/E ~24. I lay out a long trade with a clear entry, stop and target for a long-term (180 trading days) rebound if the market re-rat…
AOSL is trading at bargain multiples versus sales and book value, but trailing losses and negative free cash flow mean any upside depends on margin recovery and sustained revenue. We outline a mid-term swing trade that balances upside from mean reversion and industry tailwinds against concrete downside protections.
Lululemon trades at a single-digit to mid-teens P/E with healthy cash flow and no net debt, making it historically cheap on fundamentals. Still, leadership uncertainty and continuing U.S. softness argue for a measured, position-sized long with defined stops and a multi-month horizon.
Meta has shifted from near-zero net debt to roughly $60 billion of borrowings over the last five years to fund Reality Labs and AI infrastructure. That change amplifies downside risk despite $46.1B of free cash flow and a $1.67T market cap. We lay out a mid-term short trade that exploits near-term sentiment and valuation pressure while mapping the …
Amazon has the balance sheet, customer base, and AWS scale to develop custom silicon that matters. Short-term price action and oversold technicals create a tactical long opportunity, but execution risk and capital intensity are real. This trade targets a bounce to $230 within ~45 trading days while protecting downside at $188.
Arcturus is trading like a winner despite thin cash runway, negative free cash flow, and elevated short interest. The company has a real European approval for KOSTAIVE, but the market may already be assuming rapid commercial traction and further clinical wins. This trade idea lays out a mid-term short: entry, stop, target, catalysts to watch, and t…
Neurocrine's share drop has created a tactical long opportunity. The stock is oversold after a flurry of mixed clinical updates in late 2025; fundamentals show strong cash generation, no debt, and growing revenue. Price trades at a premium but the balance sheet and franchise support a mid-term rebound. We'll outline a specific entry, stop, and targ…
Microsoft’s Azure-led migrations are a predictable, high-margin revenue stream under the headline AI investments. The stock is down from its highs, showing technical oversold signals while fundamentals - free cash flow, ROE, and low leverage - remain robust. This trade targets a mid-term bounce as recurring migration revenue re-rates the multiple.
HubSpot fell sharply amid a broad software selloff tied to AI headlines. The selloff has pushed the stock into deeply oversold territory (RSI 22.6) despite a healthy free cash flow stream ($655M) and a $11.3B market cap. This trade idea lays out an actionable buy-the-dip plan with entry, stop and target, plus catalysts and risks.
BP halted stock buybacks to prioritize debt reduction after a weak revenue print and a $3.42B loss; the shares fell but trade at a reasonable book multiple and yield ~5%. We view this as a tactical long: enter around the current level, defend with a tight stop, and target a reversion toward the $40 area over a mid-term horizon as markets re-rate fi…
GlobalFoundries (GFS) is positioned to convert recent tech deals and policy support into faster, margin-accretive growth. The stock has already re-rated, trading near its 52-week high, but several near-term catalysts and improving technicals argue for a tactical long. This trade plan targets a measured upside while protecting against execution and …
Rubrik (RBRK) is back in the 'value bin' after a sector-wide selloff pushed shares to $52.80. The company still shows strong revenue growth, positive free cash flow, and improving profitability metrics; coupled with heavy short interest and technical oversold signals, this creates a favorable mid-term trade. We initiate a long trade with clear entr…
Amazon has been hammered since earnings, sending price below key moving averages and into oversold territory. Fundamentals remain intact: AWS profitability, solid ROE, low leverage, and a $2.14T market cap. Technicals scream oversold (RSI 23.6) and short activity is elevated — conditions that favor a tactical long for mean reversion. Trade plan pro…
